Published in Int J Fertil Womens Med on August 03, 2000
Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab (2014) 1.35
Primary hyperparathyroidism. Nat Rev Dis Prim (2016) 0.85
Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int (2016) 0.84
Eucalcemic parathyroid hormone elevation after parathyroidectomy for primary sporadic hyperparathyroidism: risk factors, trend, and outcome. Ann Surg Oncol (2011) 0.84
Successful treatment of osteitis fibrosa cystica from primary hyperparathyroidism. Case Rep Orthop (2012) 0.84
Low vitamin D levels have become less common in primary hyperparathyroidism. Osteoporos Int (2015) 0.83
Osteitis fibrosa is mediated by Platelet-Derived Growth Factor-A via a phosphoinositide 3-kinase-dependent signaling pathway in a rat model for chronic hyperparathyroidism. Endocrinology (2008) 0.82
Association between serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism. J Clin Endocrinol Metab (2013) 0.81
Primary Hyperparathyroidism: A Tale of Two Cities Revisited - New York and Shanghai. Bone Res (2013) 0.81
Primary Hyperparathyroidism. F1000Res (2016) 0.80
Characteristics of patients operated for primary hyperparathyroidism at university hospitals in Türkiye: differences among Türkiye's geographical regions. Ann Surg Treat Res (2016) 0.75
Vitamin D and primary hyperparathyroidism: more insights into a complex relationship. Endocrine (2016) 0.75
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature (2001) 6.62
Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell (1999) 6.59
Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (1997) 6.37
The galvanization of biology: a growing appreciation for the roles of zinc. Science (1996) 5.67
CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A (1997) 4.71
YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro. Nature (1991) 4.30
Mating type switching in yeast controlled by asymmetric localization of ASH1 mRNA. Science (1997) 4.23
Food and metabolic signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant. Nature (2000) 4.01
Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med (1997) 3.91
Structural basis of IAP recognition by Smac/DIABLO. Nature (2001) 3.66
Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature (2000) 3.54
The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J Virol (2000) 3.43
Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1. Proc Natl Acad Sci U S A (1993) 3.09
Structural basis of caspase-7 inhibition by XIAP. Cell (2001) 2.99
Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature (1999) 2.95
Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev (1995) 2.93
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci U S A (2001) 2.83
Dentinogenesis imperfecta 1 with or without progressive hearing loss is associated with distinct mutations in DSPP. Nat Genet (2001) 2.75
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med (1999) 2.63
Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality. Mol Cell Biol (1999) 2.61
A conserved p38 mitogen-activated protein kinase pathway regulates Drosophila immunity gene expression. Mol Cell Biol (1998) 2.57
Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding. Cell (2001) 2.39
Little emperors: behavioral impacts of China's One-Child Policy. Science (2013) 2.37
Predicting clopidogrel response using DNA samples linked to an electronic health record. Clin Pharmacol Ther (2011) 2.36
The end of the (cell) line: methods for the study of apoptosis in vitro. Methods Cell Biol (1995) 2.32
Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ (2006) 2.25
Determinants of specificity in TGF-beta signal transduction. Genes Dev (1998) 2.23
The AKT kinase is activated in multiple myeloma tumor cells. Blood (2001) 2.20
Dominant-negative p53 mutations in rheumatoid arthritis. Arthritis Rheum (1999) 2.18
Displacement of BrdUrd-induced YY1 by serum response factor activates skeletal alpha-actin transcription in embryonic myoblasts. Proc Natl Acad Sci U S A (1992) 2.15
Mouse suppressor of fused is a negative regulator of sonic hedgehog signaling and alters the subcellular distribution of Gli1. Curr Biol (1999) 2.12
Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med (1996) 2.08
Yin-yang 1 activates the c-myc promoter. Mol Cell Biol (1993) 2.06
Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development (1997) 2.05
Clinical L-type Ca(2+) channel blockade prevents ischemic preconditioning of human myocardium. J Mol Cell Cardiol (1999) 2.04
Coexisting stable conformations of gaseous protein ions. Proc Natl Acad Sci U S A (1993) 2.03
Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor. J Virol (1989) 1.96
Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. Mol Cell (2001) 1.95
Clinical clues to the cause of Addison's disease. Am J Med (1985) 1.91
The 1.9 A crystal structure of Escherichia coli MurG, a membrane-associated glycosyltransferase involved in peptidoglycan biosynthesis. Protein Sci (2000) 1.90
Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol (1995) 1.89
Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem (2001) 1.82
DAF-16 recruits the CREB-binding protein coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 cells. Proc Natl Acad Sci U S A (2000) 1.82
A giant outburst two years before the core-collapse of a massive star. Nature (2007) 1.82
Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis. Cell Death Differ (2012) 1.81
Osteoporosis and low bone mass in premenopausal and perimenopausal women. Endocr Pract (2001) 1.81
Prevalence of human respiratory viruses in adults with acute respiratory tract infections in Beijing, 2005-2007. Clin Microbiol Infect (2009) 1.76
MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene (2012) 1.74
Size dependence of Young's modulus in ZnO nanowires. Phys Rev Lett (2006) 1.74
Therapy of hypoparathyroidism with intact parathyroid hormone. Osteoporos Int (2010) 1.74
Ubiquitous overexpression of CuZn superoxide dismutase does not extend life span in mice. J Gerontol A Biol Sci Med Sci (2000) 1.74
A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol Cell Biol (1996) 1.73
Stimulation of p300-mediated transcription by the kinase MEKK1. J Biol Chem (2001) 1.72
Site-specific cleavage of DNA-RNA hybrids by zinc finger/FokI cleavage domain fusions. Gene (1997) 1.68
The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab (2008) 1.67
Spatial and molecular organization of lymph node T cell cortex: a labyrinthine cavity bounded by an epithelium-like monolayer of fibroblastic reticular cells anchored to basement membrane-like extracellular matrix. Int Immunol (2001) 1.67
Structural basis of Smad2 recognition by the Smad anchor for receptor activation. Science (2000) 1.66
FLIP and the death effector domain family. Oncogene (2008) 1.65
Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol (1999) 1.64
Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis (1999) 1.62
Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets. Diabetes (1993) 1.61
Expression and function of the leucine zipper protein Par-4 in apoptosis. Mol Cell Biol (1997) 1.59
Marked improvement in bone mass after parathyroidectomy in osteitis fibrosa cystica. J Clin Endocrinol Metab (1998) 1.58
Functional interactions between YY1 and adenovirus E1A. Nucleic Acids Res (1995) 1.58
Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J Intern Med (2005) 1.58
An exclusively nuclear RNA-binding protein affects asymmetric localization of ASH1 mRNA and Ash1p in yeast. J Cell Biol (2001) 1.58
Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes. Genome Biol (2001) 1.57
p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Res (1999) 1.57
TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot-Marie-Tooth neuropathies. Neurology (2011) 1.56
Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab (1998) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-beta receptors. EMBO J (1998) 1.54
Campylobacter-like organisms in chronic gastritis, peptic ulcer, and gastric carcinoma. Scand J Gastroenterol (1987) 1.54
The p53--Mdm2--HAUSP complex is involved in p53 stabilization by HAUSP. Oncogene (2007) 1.54
Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab (2007) 1.53
On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab (1999) 1.53
Negative regulation of the BZLF1 promoter of Epstein-Barr virus. J Virol (1991) 1.52
The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab (1990) 1.51
Multiple mechanisms of transcriptional repression by YY1. Mol Cell Biol (1997) 1.50
p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells. Genes Dev (1998) 1.50
Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure. Eur Respir J (2010) 1.48
Structural analysis of a functional DIAP1 fragment bound to grim and hid peptides. Mol Cell (2001) 1.48
A novel human gene, WSTF, is deleted in Williams syndrome. Genomics (1998) 1.47
Identification of DNA adducts of acetaldehyde. Chem Res Toxicol (2000) 1.46
A common fold for peptide synthetases cleaving ATP to ADP: glutathione synthetase and D-alanine:d-alanine ligase of Escherichia coli. Proc Natl Acad Sci U S A (1995) 1.46
A conserved transcription motif suggesting functional parallels between Caenorhabditis elegans SKN-1 and Cap'n'Collar-related basic leucine zipper proteins. J Biol Chem (2000) 1.45
Fas-mediated cell death promoted by opioids. Nature (1999) 1.45
Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism. Bone (2007) 1.43
Role for p300 in stabilization of p53 in the response to DNA damage. J Biol Chem (1999) 1.43
Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease. Int J Clin Pract (2015) 1.43
Mesenchymal stem cells: a double-edged sword in regulating immune responses. Cell Death Differ (2012) 1.41
CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J Immunol (1996) 1.41
Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300. Mol Cell Biol (1996) 1.40
Primary hyperparathyroidism: still evolving? J Bone Miner Res (1997) 1.39
Causes of childhood blindness in the People's Republic of China: results from 1131 blind school students in 18 provinces. Br J Ophthalmol (1999) 1.39
Assessment of mitral valve volume by quantitative three-dimensional echocardiography in patients with rheumatic mitral valve stenosis. Clin Cardiol (1998) 1.39
Potential gene therapy strategies in the treatment of cardiovascular disease. Ann Thorac Surg (1995) 1.39